
XEROS TECHNOLOGY GROUP PLC — Investor Relations & Filings
Xeros Technology Group is a platform technology company that develops and licenses patented, polymer-based solutions designed to reduce the environmental impact of water-intensive industrial and commercial processes. The company's core technologies significantly decrease water and energy consumption in applications across the laundry, apparel manufacturing, and textile care industries. Key products derived from its platform include advanced laundry care systems, denim finishing systems that reduce chemical and water usage, and microfibre filtration systems that capture harmful microplastics released during washing cycles. Xeros licenses its innovations to manufacturers for integration into commercial and domestic appliances.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Full Year Results 2025 | 2026-04-28 | English | |
| Notice of Results and Online Presentation | 2026-04-21 | English | |
| Purchase Order ahead of European Launch of XF3 | 2026-03-05 | English | |
| Holding(s) in Company | 2026-02-11 | English | |
| Board Change | 2026-02-02 | English | |
| Trading Update | 2026-01-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 37867319 | Full Year Results 2025 | 2026-04-28 | English | ||
| 34696765 | Notice of Results and Online Presentation | 2026-04-21 | English | ||
| 34566383 | Purchase Order ahead of European Launch of XF3 | 2026-03-05 | English | ||
| 34558682 | Holding(s) in Company | 2026-02-11 | English | ||
| 13940275 | Board Change | 2026-02-02 | English | ||
| 13384794 | Trading Update | 2026-01-27 | English | ||
| 12198784 | TR-1 First Equity | 2026-01-07 | English | ||
| 11758552 | Block listing Interim Review | 2026-01-02 | English | ||
|
2025
7 filings
| |||||
| 9844248 | TR-1 Entrepreneurs Fund | 2025-12-11 | English | ||
| 9073168 | TR-1 Lombard Odier | 2025-12-02 | English | ||
| 9059516 | TR-1 Dowgate | 2025-12-02 | English | ||
| 9042376 | TR-1 Maven | 2025-12-02 | English | ||
| 8779881 | Results of General Meeting and Director Dealings | 2025-11-28 | English | ||
| 8730717 | Result of Follow-on Subscription and TVR | 2025-11-27 | English | ||
| 8684636 | TR-1 Spreadex | 2025-11-26 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for XEROS TECHNOLOGY GROUP PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
XEROS TECHNOLOGY GROUP PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/8027/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=8027 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=8027 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=8027 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 8027}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for XEROS TECHNOLOGY GROUP PLC (id: 8027)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.